Get With the Guidelines-Stroke Registry
Launched by AMERICAN HEART ASSOCIATION · Feb 23, 2016
Trial Information
Current as of August 21, 2025
Recruiting
Keywords
ClinConnect Summary
The Get With The Guidelines-Stroke Registry is a clinical trial aimed at improving the care of patients who have had a stroke. This program focuses on ensuring that hospitals follow the best practices and latest guidelines for treating stroke patients. The goal is to help patients receive the best possible treatment when they are admitted to the hospital for their condition.
To be eligible for this trial, participants should be adults aged 18 and older who have been diagnosed with specific types of strokes, such as ischemic stroke (where a blood clot blocks blood flow to the brain) or other related conditions. If you join the study, you can expect to help researchers learn how to better manage stroke care in hospitals, which may ultimately improve outcomes for future patients. The trial is currently recruiting participants, and everyone, regardless of gender, is welcome to take part as long as they meet the eligibility criteria.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients presented with a diagnosis of Ischemic stroke or transient ischemic attack, Subarachnoid hemorrhage, Intracerebral hemorrhage, or Stroke not otherwise specified to the hosptials.
- Exclusion Criteria:
- • Patients who do not have a diagnosis of Ischemic stroke or transient ischemic attack, Subarachnoid hemorrhage, Intracerebral hemorrhage, or Stroke not otherwise specified.
- • Patients under age of 18
About American Heart Association
The American Heart Association (AHA) is a leading non-profit organization dedicated to advancing cardiovascular health through research, education, and advocacy. With a mission to reduce the prevalence of heart disease and stroke, the AHA sponsors a range of clinical trials aimed at improving patient outcomes and advancing scientific knowledge in cardiovascular medicine. By fostering collaboration among healthcare professionals, researchers, and communities, the AHA plays a pivotal role in shaping public health policies and promoting evidence-based practices that enhance the quality of care for individuals affected by cardiovascular conditions. Through its commitment to rigorous research and innovation, the AHA continues to be at the forefront of efforts to combat heart disease and improve the overall health of populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Dallas, Texas, United States
Dallas, Texas, United States
Dallas, Texas, United States
Patients applied
Trial Officials
Javed Butler, MD
Study Director
American Heart Association
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials